Clinical Trial Update: Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of capecitabine, vinorelbine, and trastuzumab in metastatic breast cancer; results from the study have been posted. Spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)
• Trastuzumab (Herceptin) (trastuzumab)
• Vinorelbine (Navelbine) (vinorelbine tartrate)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-01-23